Trial intelligence / Profile preview

SUSPEND trial for medical expulsive therapy in ureteric stones

ISRCTN69423238Phase 3Completed

Sponsor
University of Aberdeen
Start
Jan 2011
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial in ureterolithiasis comparing Nifedipine, Tamsulosin and Placebo (3 arms). Primary endpoints: Spontaneous passage of ureteric stones at four weeks and Incremental cost per quality-adjusted life year gained. Started Jan 2011; status: completed.

02

Drugs

nifedipinetamsulosin
03

Conditions

ureterolithiasis

Beyond the preview

Go deeper on ISRCTN69423238.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN69423238.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call